The effect of sitagliptin on myocardial performance in patients with type 2 diabetes and coronary artery disease.
Phase of Trial: Phase IV
Latest Information Update: 09 Apr 2014
At a glance
- Drugs Sitagliptin (Primary)
- Indications Coronary artery disease; Left ventricular dysfunction; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 15 Jun 2011 New trial record